Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66.4M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+121K
-
Total reported value, excl. options
-
$55.5M
-
Value change
-
+$377K
-
Put/Call ratio
-
0.5
-
Number of buys
-
14
-
Number of sells
-
-8
-
Price
-
$3.10
Significant Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q4 2024
38 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q4 2024.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 66.4M outstanding shares and own 27.09% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), BANQUE PICTET & CIE SA (2.24M shares), AKRE CAPITAL MANAGEMENT LLC (2.24M shares), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (2.2M shares), PRINCIPAL FINANCIAL GROUP INC (1.43M shares), Alta Wealth Advisors LLC (1.41M shares), MILLENNIUM MANAGEMENT LLC (699K shares), Bank Pictet & Cie (Europe) AG (223K shares), EDMOND DE ROTHSCHILD HOLDING S.A. (203K shares), and FEDERATED HERMES, INC. (100K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.